Canntab Therapeutics Ltd
OTC:CTABF
Shareholder Yield
Current shareholder yield for CTABF is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CTABF Price
Canntab Therapeutics Ltd
| Average Annual Return | -44.25% |
| Standard Deviation of Annual Returns | 50.21% |
| Max Drawdown | -100% |
| Market Capitalization | 194.5k USD |
| Shares Outstanding | 38 909 200 |
| Percentage of Shares Shorted |
N/A
|
CTABF Return Decomposition
Main factors of price return
Stock Splits
CTABF's latest stock split occurred on Apr 20, 2018
The company executed a 1-for-200 stock split, meaning that for every 200 shares held, investors received 1 new share.
Before the split, CTABF traded at 9.88 per share. Afterward, the share price was about 9.88.
The adjusted shares began trading on Apr 20, 2018. This was the only stock split in CTABF's history.
